Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
J Mol Cell Cardiol ; 88: 39-54, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26392029

RESUMO

Cardiac remodeling, a hallmark of heart disease, is associated with intense auto- and paracrine signaling leading to cardiac fibrosis. We hypothesized that the specific mediator of Gq/11-dependent RhoA activation p63RhoGEF, which is expressed in cardiac fibroblasts, plays a role in the underlying processes. We could show that p63RhoGEF is up-regulated in mouse hearts subjected to transverse aortic constriction (TAC). In an engineered heart muscle model (EHM), p63RhoGEF expression in cardiac fibroblasts increased resting and twitch tensions, and the dominant negative p63ΔN decreased both. In an engineered connective tissue model (ECT), p63RhoGEF increased tissue stiffness and its knockdown as well as p63ΔN reduced stiffness. In 2D cultures of neonatal rat cardiac fibroblasts, p63RhoGEF regulated the angiotensin II (Ang II)-dependent RhoA activation, the activation of the serum response factor, and the expression and secretion of the connective tissue growth factor (CTGF). All these processes were inhibited by the knockdown of p63RhoGEF or by p63ΔN likely based on their negative influence on the actin cytoskeleton. Moreover, we show that p63RhoGEF also regulates CTGF in engineered tissues and correlates with it in the TAC model. Finally, confocal studies revealed a closely related localization of p63RhoGEF and CTGF in the trans-Golgi network.


Assuntos
Fator de Crescimento do Tecido Conjuntivo/genética , Fibroblastos/metabolismo , Miocárdio/metabolismo , Fatores de Troca de Nucleotídeo Guanina Rho/genética , Fator de Resposta Sérica/genética , Proteína rhoA de Ligação ao GTP/genética , Citoesqueleto de Actina/metabolismo , Citoesqueleto de Actina/ultraestrutura , Angiotensina II/genética , Angiotensina II/metabolismo , Animais , Animais Recém-Nascidos , Aorta/cirurgia , Comunicação Autócrina/genética , Fator de Crescimento do Tecido Conjuntivo/metabolismo , Constrição , Feminino , Fibroblastos/patologia , Fibroblastos/ultraestrutura , Regulação da Expressão Gênica , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Modelos Cardiovasculares , Miocárdio/patologia , Comunicação Parácrina/genética , Ratos , Ratos Wistar , Fatores de Troca de Nucleotídeo Guanina Rho/metabolismo , Fator de Resposta Sérica/metabolismo , Transdução de Sinais , Remodelação Ventricular , Proteína rhoA de Ligação ao GTP/metabolismo , Rede trans-Golgi/metabolismo , Rede trans-Golgi/ultraestrutura
2.
Urology ; 156: 147-153, 2021 10.
Artigo em Inglês | MEDLINE | ID: mdl-34186136

RESUMO

OBJECTIVE: To report feasibility and outcome of salvage robotic-assisted laparoscopic radical prostatectomy (S-RALP) after focal therapy using high-intensity focused ultrasound (HIFU) treatment compared to primary robotic-assisted laparoscopic radical prostatectomy (pRALP). METHODS: In this bicentric trial patients undergoing S-RALP for detection of WHO2016/ISUP Grade Group 2 or 3 prostate cancer were previously treated in prospective focal HIFU trials. Perioperative data, complications, oncological and functional outcome were analysed. Patients who underwent pRALP were matched in a ratio 2(pRALP):1(S-RALP) according to preoperatively functional, oncological and clinical parameters. RESULTS: A total of 39 patients were included in the study (13S-RALP, 26pRALP). Median operative time in the S-RALP group was 260minutes (pRALP: 257minutes), blood loss was 230ml (pRALP: 300ml). Complications occurred in 46.2% (6/13) of S-RALP patients (pRALP: 26.9%), including four Clavien-Dindo III complications (pRALP: 2/26). In S-RALP adverse histological outcome (≥pT3a, pN+ or R1) was detected in 23.1% (3/13) (pRALP: 26.9%). There was one patient with PSA-persistence (pRALP: 2/26). Regarding functional outcomes there was no difference between the two groups observed (incontinence P=.71, erectile function P=.21). CONCLUSION: S-RALP should be offered to patients with an early relapse after focal HIFU. The early oncological outcome is satisfactory and functional outcome one year postoperatively is similar to pRALP. However, S-RALP is associated with a higher rate of Clavien-Dindo III complications (mainly, placement of a drainage), of which patients should be informed beforehand.


Assuntos
Disfunção Erétil , Tratamento por Ondas de Choque Extracorpóreas/métodos , Complicações Pós-Operatórias , Prostatectomia , Neoplasias da Próstata , Procedimentos Cirúrgicos Robóticos , Terapia de Salvação , Incontinência Urinária , Perda Sanguínea Cirúrgica/estatística & dados numéricos , Terapia Combinada/métodos , Pesquisa Comparativa da Efetividade , Disfunção Erétil/diagnóstico , Disfunção Erétil/etiologia , Humanos , Masculino , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Avaliação de Processos e Resultados em Cuidados de Saúde , Complicações Pós-Operatórias/etiologia , Complicações Pós-Operatórias/terapia , Antígeno Prostático Específico/análise , Prostatectomia/efeitos adversos , Prostatectomia/métodos , Neoplasias da Próstata/sangue , Neoplasias da Próstata/patologia , Neoplasias da Próstata/fisiopatologia , Neoplasias da Próstata/terapia , Procedimentos Cirúrgicos Robóticos/efeitos adversos , Procedimentos Cirúrgicos Robóticos/métodos , Terapia de Salvação/efeitos adversos , Terapia de Salvação/métodos , Incontinência Urinária/diagnóstico , Incontinência Urinária/etiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA